Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery

Bioconjugate Chemistry

Volumn 25, Issue 7, 2014, Pages 1261-1271

  Alexander, Colleen M ^a   Hamner, Kristen L ^a   Maye, Mathew M ^a   Dabrowiak, James C ^a  

^a SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; DNA; DURABILITY; ETHYLENE; ETHYLENE GLYCOL; FIBER OPTIC SENSORS; GOLD NANOPARTICLES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METAL NANOPARTICLES; MOLECULAR BIOLOGY; OLIGOMERS; POLYETHYLENE GLYCOLS; POLYOLS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

ANTICANCER DRUG; CYTOTOXIC; DELIVERY VEHICLE; DOXORUBICIN; EXPOSURE-TIME; FOLIC ACIDS; NEUROBLASTOMA CELLS; PROPERTY; RECOVERY TIME; THERMORESPONSIVE POLYMER;

ORGANIC ACIDS;

AMINO ACID; DOUBLE STRANDED DNA; DOXORUBICIN; DRUG VEHICLE; ETHYLENE GLYCOL DERIVATIVE; FOLIC ACID; GOLD NANOPARTICLE; HEXAETHYLENE GLYCOL; MACROGOL; OLIGOMER; POLYMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; DRUG CARRIER; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; N-HYDROXYSUCCINIMIDE; SUCCINIMIDE DERIVATIVE;

ARTICLE; BINDING AFFINITY; CANCER CHEMOTHERAPY; CARBON NUCLEAR MAGNETIC RESONANCE; CELL GROWTH; CELL POPULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DNA STRAND; DRUG ACCUMULATION; DRUG BINDING SITE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DNA INTERACTION; DRUG EXPOSURE; DRUG SYNTHESIS; DRUG TARGETING; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; INFRARED SPECTROSCOPY; ION EXCHANGE CHROMATOGRAPHY; LIGHT SCATTERING; MOLECULAR WEIGHT; NEUROBLASTOMA CELL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROPHOTOMETRY; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; NEUROBLASTOMA; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL PROLIFERATION; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLIC ACID; GOLD; HUMANS; METAL NANOPARTICLES; MOLECULAR STRUCTURE; NEUROBLASTOMA; POLYETHYLENE GLYCOLS; POLYMERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; SUCCINIMIDES; TUMOR CELLS, CULTURED;

EID: 84904444155     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc500136r     Document Type: Article

References (41)

1. Murphy, C. J., Gole, A. M., Stone, J. W., Sisco, P. N., Alkilany, A. M., Goldsmith, E. C., and Baxter, S. C. (2008) Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc. Chem. Res. 41, 1721-1730
2. Fadeel, B. and Garcia-Bennett, A. E. (2010) Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications Adv. Drug Delivery Rev. 62, 362-374
3. Dreaden, E. C., Mackey, M. A., Huang, X., Kangy, B., and El-Sayed, M. A. (2011) Beating cancer in multiple ways using nanogold Chem. Soc. Rev. 40, 3391-3404
4. Rana, S., Bajaj, A., Mout, R., and Rotello, V. M. (2012) Monolayer coated gold nanoparticles for delivery applications Adv. Drug. Delivery Rev. 64, 200-16
5. Giljohnn, D. A., Seferos, D. S., Danial, W. L., Massich, M. D., Patel, P. C., and Mirkin, C. A. (2010) Gold nanoparticles for biology and medicine Angew. Chem., Int. Ed. Engl. 49, 3280-94
6. Mieszawaka, A. J., Mulder, W. J., Fayad, Z. A., and Cormode, D. P. (2013) Multifunctional gold nanoparticles for diagnosis and therapy of disease Mol. Pharmacol. 10, 831-47
7. Liu, A. and Ye, B. (2013) Application of gold nanoparticles in biomedical researches and diagnosis Clin. Lab. 59, 23-36
8. Liu, J., Yu, M., Zhou, C., Yang, S., Ning, X., and Zheng, J. (2013) Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance J. Am. Chem. Soc. 135, 4978-4981
9. Feng, S. S. and Chien, S. (2003) Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases Chem. Eng. Sci. 58, 4087-4114
10. Yeh, E. T. H. and Bickford, C. L. (2009) Cardiovascular complications of cancer therapy J. Am. Coll. Cardiol. 53, 2231-2247
11. Cai, W. (2008) Applications of gold nanoparticles in cancer nanotechnology Nanotechnol. Sci. Appl. 1, 17-32
12. Kim, C. k., Ghosh, P., and Rotello, V. M. (2009) Multimodal drug delivery using gold nanoparticles Nanoscale 1, 61-7
13. Kumar, A., Zhang, X., and Liang, X. J. (2013) Gold nanoparticles: emerging paradigm for targeted drug delivery Biotechnol. Adv. 31, 593-606
14. Powell, A. C., Paciotti, G. F., and Libutti, S. K. (2010) Colloidal gold: a novel nanoparticle for targeted cancer therapeutics Methods Mol. Biol. 624, 375-84
15. Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., and Liang, X.-J. (2012) Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment Biomaterials 33, 1180-1189
16. Arosio, D., Manzoni, L., Araldi, E. M., and Scolastico, C. (2011) Cyclic RGD functionalized gold nanoparticles for tumor targeting Bioconjugate Chem. 22, 664-72
17. Nasrolahi Shirazi, A., Mandal, D., Tiwari, R. K., Guo, L., Lu, W., and Parang, K. (2013) Cyclic peptide-capped gold nanoparticles as drug delivery systems Mol. Pharmacol. 10, 500-11
18. Cheng, Y., Doane, T. L., Chuang, C. H., Ziady, A., and Burda, C. (2014) Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy Small 10.1002/smll.201303329
19. Cheng, Y., Meyers, J. D., Broome, A. M., Kenney, M. E., Basilion, J. P., and Burda, C. (2011) Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates J. Am. Chem. Soc. 133, 2583-91
20. Meyers, J. D., Doane, T., Burda, C., and Basilion, J. P. (2013) Nanoparticles for imaging and treating brain cancer Nanomedicine (London) 8, 123-43
21. Cheng, Y., Meyers, J. D., Agnes, R. S., Doane, T. L., Kenney, M. E., Broome, A.-M., Burda, C., and Basilion, J. P. (2011) Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? Small 7, 2301-2306
22. Leamon, C. P. and Low, P. S. (2001) Folate-mediated targeting: from diagnostics to drug and gene delivery Drug Discovery Today 6, 44-51
23. Zhao, X., Li, H., and Lee, R. J. (2008) Targeted drug delivery via folate receptors Expert Opin. Drug Delivery 5, 309-19
24. Llevot, A. and Astruc, D. (2012) Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer Chem. Soc. Rev. 41, 242-57
25. Drbohlavova, J., Chomoucka, J., Adam, V., Ryvolova, M., Eckschlager, T., Hubalek, J., and Kizek, R. (2013) Nanocarriers for anticancer drugs-new trends in nanomedicine Curr. Drug Metab. 14, 547-64
26. Low, P. S., Henne, W. A., and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases Acc. Chem. Res. 41, 120-129
27. Leamon, C. P. and Low, P. S. (1991) Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis Proc. Natl. Acad. Sci. U.S.A. 88, 5572-5576
28. Gautier, J., Allard-Vannier, E., Munnier, E., Soucé, M., and Chourpa, I. (2013) Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles J. Controlled Release 169, 48-61
29. Cheng, J., Gu, Y. J., Cheng, S. H., and Wong, W. T. (2013) Surface functionalized gold nanoparticles for drug delivery J. Biomed. Nanotechnol. 9, 1362-9
30. Alexander, C. M., Dabrowiak, J. C., and Maye, M. M. (2011) DNA-capped nanoparticles designed for doxorubicin drug delivery Chem. Commun. 47, 3418-3420
31. Alexander, C. M., Dabrowiak, J. C., and Maye, M. M. (2012) Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D Bioconjugate Chem. 23, 2061-2070
32. Hamner, K. L., Alexander, C. M., Coopersmith, K., Reishofer, D., Provenza, C., and Maye, M. M. (2013) Using temperature sensitive smart polymers to regulate DNA-mediated nano assembly and encoded nano carrier drug release ACS Nano 7, 7011-7020
33. Albanese, A., Tang, P. S., and Chan, W. C. W. (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu. Rev. Biomed. Eng. 14, 1-16
34. Blum, R. H. and Carter, S. K. (1974) Adriamycin. A new anticancer drug with significant clinical activity Ann. Int. Med. 80, 249-59
35. Donaldson, M. H. (1972) Proceedings: Treatment of neuroblastoma-1972 Proc. Natl. Cancer Conf. 7, 605-9
36. Cheung, N. V. and Heller, G. (1991) Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma J. Clin. Oncol. 9, 1050-8
37. Dixit, V., Van den Bossche, J., Sherman, D. M., Thompson, D. H., and Andres, R. P. (2006) Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells Bioconjugate Chem. 17, 603-609
38. Aronov, O., Horowitz, A. T., Gabizon, A., and Gibson, D. (2003) Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies Bioconjugate Chem. 14, 563-574
39. Zhang, K., Wang, Q., Xie, Y., More, G., Sega, E., Low, P. S., and Huang, Y. (2008) Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions RNA 14, 577-583
40. Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., and Liu, L. F. (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II Science 226, 466-468
41. Eustis, S. and El-Sayed, M. A. (2006) Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes Chem. Soc. Rev. 35, 209-217